Fig. 3.
Fig. 3. cPLA2 mRNA levels during sepsis and after recovery. / (A) A representative RT-PCR experiment assessing cPLA2 mRNA levels of a septic patient manifesting elevated cPLA2protein activity and expression. The amplified products of cPLA2 (628 bp) and the corresponding products of β-actin (269 bp) are shown. The PCR reactions were amplified for 25, 35, and 45 cycles (A, B, and C, respectively). The first lane shows the 123 bp size marker. (B) cPLA2 mRNA levels in human neutrophils during sepsis and after recovery. The levels of cPLA2 mRNA in neutrophils of the septic patients with increased cPLA2and the controls were quantitated by densitometry and divided by the corresponding actin mRNA levels. The mean ± SEM of the densitometry analysis in the septic patients and the controls are shown. The densitometric analysis demonstrates that cPLA2 mRNA levels are significantly higher (P < 0.001) during the disease than after recovery.

cPLA2 mRNA levels during sepsis and after recovery.

(A) A representative RT-PCR experiment assessing cPLA2 mRNA levels of a septic patient manifesting elevated cPLA2protein activity and expression. The amplified products of cPLA2 (628 bp) and the corresponding products of β-actin (269 bp) are shown. The PCR reactions were amplified for 25, 35, and 45 cycles (A, B, and C, respectively). The first lane shows the 123 bp size marker. (B) cPLA2 mRNA levels in human neutrophils during sepsis and after recovery. The levels of cPLA2 mRNA in neutrophils of the septic patients with increased cPLA2and the controls were quantitated by densitometry and divided by the corresponding actin mRNA levels. The mean ± SEM of the densitometry analysis in the septic patients and the controls are shown. The densitometric analysis demonstrates that cPLA2 mRNA levels are significantly higher (P < 0.001) during the disease than after recovery.

Close Modal

or Create an Account

Close Modal
Close Modal